Novartis AG (NVSEF)
163.60
+5.99
(+3.80%)
USD |
OTCM |
Aug 24, 16:00
Novartis 1 Year Total Returns (Daily) : 32.94% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 32.94% |
| August 21, 2026 | 28.08% |
| August 20, 2026 | 28.57% |
| August 19, 2026 | 36.49% |
| August 18, 2026 | 27.73% |
| August 17, 2026 | 24.49% |
| August 14, 2026 | 40.85% |
| August 13, 2026 | 40.85% |
| August 12, 2026 | 40.85% |
| August 11, 2026 | 40.85% |
| August 10, 2026 | 36.12% |
| August 07, 2026 | 37.29% |
| August 06, 2026 | 37.29% |
| August 05, 2026 | 39.22% |
| August 04, 2026 | 40.54% |
| August 03, 2026 | 34.94% |
| July 31, 2026 | 40.80% |
| July 30, 2026 | 40.19% |
| July 29, 2026 | 38.91% |
| July 28, 2026 | 33.81% |
| July 27, 2026 | 33.81% |
| July 24, 2026 | 38.09% |
| July 23, 2026 | 38.98% |
| July 22, 2026 | 37.66% |
| July 21, 2026 | 32.80% |
| Date | Value |
|---|---|
| July 20, 2026 | 32.80% |
| July 17, 2026 | 31.89% |
| July 16, 2026 | 31.89% |
| July 15, 2026 | 26.89% |
| July 14, 2026 | 27.21% |
| July 13, 2026 | 30.24% |
| July 10, 2026 | 30.24% |
| July 09, 2026 | 35.62% |
| July 08, 2026 | 36.24% |
| July 07, 2026 | 35.57% |
| July 06, 2026 | 34.08% |
| July 02, 2026 | 29.04% |
| July 01, 2026 | 25.08% |
| June 30, 2026 | 31.69% |
| June 29, 2026 | 31.69% |
| June 26, 2026 | 37.26% |
| June 25, 2026 | 36.88% |
| June 24, 2026 | 34.79% |
| June 23, 2026 | 32.77% |
| June 22, 2026 | 25.09% |
| June 18, 2026 | 28.65% |
| June 17, 2026 | 25.35% |
| June 16, 2026 | 27.14% |
| June 15, 2026 | 25.25% |
| June 12, 2026 | 26.50% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Roche Holding AG | 44.96% |
| Addex Therapeutics Ltd. | -53.61% |
| Oculis Holding AG | -26.16% |
| Sandoz Group AG | 47.36% |
| Galderma Group AG | 26.02% |